Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Moderna & IBM Work Together To Support Smarter Real-Time COVID-19 Vaccine Adoption & Management

By John F. Heerdink, Jr.

Reportedly, Vaccine maker Moderna Inc. (MRNA) and International Business Machines Corporation (IBM) join hands to work together on technologies including artificial intelligence, blockchain, and hybrid cloud to track COVID-19 vaccine administration. The aim is to identify ways technology can be used to help gather and secure information to be shared between governments, healthcare providers, and individuals improving confidence in vaccine programs and increase the speed of vaccination in order to control the spread at the earliest.

The initial work is to focus on exploring the utility of IBM capabilities in the U.S. offering vaccine management solutions that provide end-to-end traceability to address potential supply chain disruptions. Built on blockchain technology, Digital Health Pass is an advanced solution designed to assist individuals to have control of their personal health information and share it in a secured, verifiable, and trusted manner.

“Moderna is committed to working with a coalition of partners to increase education and awareness of the importance of vaccination to help defeat COVID-19,” “We look forward to working with IBM to apply digital innovations to build connections between organizations, governments, and individuals to instill confidence in COVID-19 vaccines.” stated Michael Mullette, VP, Managing Director North America Commercial Operations of Moderna.

Jason Kelley, Managing Partner, Global Strategic Alliances Leader for IBM stated, “If ever there was a time to rally around open technology and collaboration, it’s now,” , “As governments, pharmacy chains, healthcare providers, and life sciences companies continue to scale and connect their tools, and as new players enter the supply chain, open technology can help drive more transparency and bolster trust, while helping to ensure accessibility and equity in the process.”

IBM’s joint efforts with Moderna align with its efforts to help address the COVID-19 by allowing access to its diverse technology portfolio.

Dow 30 component International Business Machines Corporation (IBM) provides information technology (IT) products and services worldwide. To learn more about International Business Machines Corp (IBM) and to track its ongoing progress please visit the Vista Partners IBM Coverage Page


Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.


(Read Original Story: Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing in PR Newswire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us